| An overview of ADAM9: structure, activation, and regulation in human diseases CW Chou, YK Huang, TT Kuo, JP Liu, YP Sher International Journal of Molecular Sciences 21 (20), 7790, 2020 | 74 | 2020 |
| ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis KL Chiu, YS Lin, TT Kuo, CC Lo, YK Huang, HF Chang, EY Chuang, ... Oncotarget 8 (29), 47365, 2017 | 31 | 2017 |
| Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression CC Lin, YK Huang, CF Cho, YS Lin, CC Lo, TT Kuo, GC Tseng, ... Theranostics 10 (24), 10925, 2020 | 24 | 2020 |
| ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma YS Lin, TT Kuo, CC Lo, WC Cheng, WC Chang, GC Tseng, ST Bai, ... International journal of biological sciences 17 (14), 3898, 2021 | 10 | 2021 |
| Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy YK Huang, WC Cheng, TT Kuo, JC Yang, YC Wu, HH Wu, CC Lo, ... Nature Cancer 5 (3), 400-419, 2024 | 2 | 2024 |
